NS Reps to LTC

[anonymous]

Thoughts on what will happen with this move announced today?

 

[anonymous]

There was nothing announced..?

Thoughts on what will happen with this move announced today?

 

[anonymous]

There was nothing announced..?

Yes there was. NS reps moving to LTC

 

[anonymous]

Good move since Ajovy has struggled since the launch, being 3rd migraine med to the game and revenue will never be fruitful to support 2nd product in bag with current NS headcount. No wonder they decided not to back fill the NS openings, since Austedo is the future. Great opportunities for added voice in LTC where there hasn't been a ton of penetration yet and when QD dosing comes early next year with Austedo, added to all the great long term data, this decision was a no brainer. The psychiatry teams can stay in their lanes and start converting all that BID business to QD while assisting NH with the launch of Uzedy in Q-1. If you have a current opening in your territory that was once NS, be ready for some shuffling and territory product responsibility changes. Everyone will have a spot unless you decide you don't want to change business units. If not, then see ya later.

 

[anonymous]

There was nothing announced..?

You might want to get your head out of your ass. If you missed the "NS business unit only call" this morning, then you might need to talk to our manager. Or here's a thought, try reading your e-mail and Outlook calendar one in a while.

 

[anonymous]

Good move since Ajovy has struggled since the launch, being 3rd migraine med to the game and revenue will never be fruitful to support 2nd product in bag with current NS headcount. No wonder they decided not to back fill the NS openings, since Austedo is the future. Great opportunities for added voice in LTC where there hasn't been a ton of penetration yet and when QD dosing comes early next year with Austedo, added to all the great long term data, this decision was a no brainer. The psychiatry teams can stay in their lanes and start converting all that BID business to QD while assisting NH with the launch of Uzedy in Q-1. If you have a current opening in your territory that was once NS, be ready for some shuffling and territory product responsibility changes. Everyone will have a spot unless you decide you don't want to change business units. If not, then see ya later.

QD dosing will have some baggage. It's too quiet.

 

[anonymous]

QD dosing will have some baggage. It's too quiet.

 

[anonymous]

did we deuterize deuterized tetrabenazine? Lol. What the what? We’re still a “sell” by most analysts, I don’t see this coming to market anytime soon. What do I know, I’m just a minion in the field getting nothing accomplished.